Tarsus Pharmaceuticals’ Xdemvy demonstrates positive efficacy and safety in treatment for patients with Demodex blepharitis.
Xdemvy is the first and only approved FDA treatment for Demodex blepharitis Xdemvy can achieve collarette reduction of no more ...
